Suppression of bone resorption from odanacatib, a cathepsin K inhibitor, in women with bone metastases from breast cancer, and the effect of concomitant anti-neoplastic treatment on efficacy: A 4-week, double-blind, randomized controlled trial

Authors
Category Primary study
JournalCancer Research
Year 2009
This article has no abstract
Epistemonikos ID: 70c84dbf3206168ac9f8967743e84bcb6b38d74e
First added on: Feb 28, 2025